drugset / Trial / NCT00275912

Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures

NCT00275912

Phase 4 Completed 60 enrolled Novartis
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is aimed to collect additional data regarding the efficacy in reducing the frequency of partial seizures, as well as the safety and tolerability, of oxcarbazepine monotherapy in children.

Timeline

Start
2006-09-11
Primary completion
2007-09-28
Completion
2007-09-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxcarbazepine Small molecule

Indications